In this study, we extended our previous study of SEMA3s [11] to SEMA3 receptors to test the correlation between their expression and tumor infiltrates, as well as their association with the expression of immune blockade molecules PD1/PDL1 and CTLA-4 in cancer TME. The gene discussed is CD274; the disease is cancer.